Novel antibodies detect additional a-synuclein pathology in synucleinopathies: potential development for immunotherapy. (2020)
Attributed to:
Clinical Neuroanatomy - Experimental model for immunotherapy for synucleinopathies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13195-020-00727-x
PubMed Identifier: 33256825
Publication URI: http://europepmc.org/abstract/MED/33256825
Type: Journal Article/Review
Volume: 12
Parent Publication: Alzheimer's research & therapy
Issue: 1